APA
Click to copy
Domínguez, J., Boeree, M., Cambau, E., Chesov, D., Conradie, F., Cox, V., … Lange, C. (2023). Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. Lancet. Infectious Diseases (Print).
Chicago/Turabian
Click to copy
Domínguez, J., M. Boeree, E. Cambau, D. Chesov, F. Conradie, V. Cox, K. Dheda, et al. “Clinical Implications of Molecular Drug Resistance Testing for Mycobacterium Tuberculosis: a 2023 TBnet/RESIST-TB Consensus Statement.” Lancet. Infectious Diseases (Print) (2023).
MLA
Click to copy
Domínguez, J., et al. “Clinical Implications of Molecular Drug Resistance Testing for Mycobacterium Tuberculosis: a 2023 TBnet/RESIST-TB Consensus Statement.” Lancet. Infectious Diseases (Print), 2023.
BibTeX Click to copy
@article{j2023a,
title = {Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement.},
year = {2023},
journal = {Lancet. Infectious Diseases (Print)},
author = {Domínguez, J. and Boeree, M. and Cambau, E. and Chesov, D. and Conradie, F. and Cox, V. and Dheda, K. and Dudnyk, A. and Farhat, M. and Gagneux, S. and Grobusch, M. and Gröschel, M. and Guglielmetti, L. and Kontsevaya, I. and Lange, Berit and van Leth, F. and Lienhardt, C. and Mandalakas, A. and Maurer, F. and Merker, M. and Miotto, P. and Molina-Moya, B. and Morel, Florence and Niemann, S. and Veziris, N. and Whitelaw, A. and Horsburgh, C. and Lange, C.}
}